BioLight announced that its IOPtima subsidiary has signed an exclusive distribution agreement for the sale and marketing of the IOPtiMateTM system in China, one of the world’s largest glaucoma markets. As part of the agreement, IOPtima received a commitment that at least 100 systems will be purchased during the initial term of the agreement.
Link to Newsroom